EFG Asset Management Americas Corp. Has $8.73 Million Stake in CME Group Inc. (NASDAQ:CME)

EFG Asset Management Americas Corp. decreased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 10.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,467 shares of the financial services provider's stock after selling 4,750 shares during the period. CME Group comprises 1.9% of EFG Asset Management Americas Corp.'s portfolio, making the stock its 9th largest holding. EFG Asset Management Americas Corp.'s holdings in CME Group were worth $8,733,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new stake in shares of CME Group in the 4th quarter valued at approximately $610,482,000. Morgan Stanley increased its holdings in shares of CME Group by 31.5% in the 3rd quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider's stock valued at $972,863,000 after purchasing an additional 1,163,103 shares in the last quarter. Barclays PLC increased its holdings in shares of CME Group by 90.0% in the 2nd quarter. Barclays PLC now owns 1,218,481 shares of the financial services provider's stock valued at $225,771,000 after purchasing an additional 577,293 shares in the last quarter. 1832 Asset Management L.P. increased its holdings in shares of CME Group by 992.8% in the 1st quarter. 1832 Asset Management L.P. now owns 623,999 shares of the financial services provider's stock valued at $119,508,000 after purchasing an additional 566,899 shares in the last quarter. Finally, Alliancebernstein L.P. increased its holdings in shares of CME Group by 71.1% in the 4th quarter. Alliancebernstein L.P. now owns 1,307,658 shares of the financial services provider's stock valued at $219,896,000 after purchasing an additional 543,507 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Price Performance

CME Group stock traded up $3.39 during midday trading on Friday, reaching $213.04. 2,563,922 shares of the company were exchanged, compared to its average volume of 1,525,048. CME Group Inc. has a 1 year low of $175.73 and a 1 year high of $223.80. The firm's 50-day simple moving average is $214.42 and its 200-day simple moving average is $211.83. The company has a market capitalization of $76.69 billion, a price-to-earnings ratio of 24.02, a P/E/G ratio of 6.04 and a beta of 0.49. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.27 by $0.10. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the business earned $1.92 earnings per share. CME Group's revenue was up 19.2% compared to the same quarter last year. On average, analysts anticipate that CME Group Inc. will post 9.57 EPS for the current year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Thursday, March 7th. This is an increase from CME Group's previous quarterly dividend of $1.10. This represents a $4.60 annualized dividend and a yield of 2.16%. CME Group's dividend payout ratio is 51.86%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of research reports. Argus upped their price target on CME Group from $225.00 to $245.00 and gave the stock a "buy" rating in a report on Wednesday, March 6th. The Goldman Sachs Group cut CME Group from a "neutral" rating to a "sell" rating and set a $195.00 price target on the stock. in a report on Wednesday, January 3rd. Rosenblatt Securities reiterated a "sell" rating and issued a $180.00 price objective on shares of CME Group in a research report on Thursday, January 4th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a $210.00 price objective (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Barclays boosted their price objective on shares of CME Group from $225.00 to $226.00 and gave the stock an "equal weight" rating in a research report on Monday, April 8th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, CME Group presently has a consensus rating of "Hold" and a consensus target price of $215.70.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.